Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
18.35
+0.97 (5.58%)
Aug 13, 2026, 1:26 PM EDT - Market open
IART Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,648 | 1,635 | 1,611 | 1,542 | 1,558 | 1,542 | |
Revenue Growth | 1.60% | 1.54% | 4.47% | -1.03% | 0.99% | 12.43% |
Cost of Revenue | 783.08 | 803.63 | 728.47 | 656.84 | 587.36 | 597.81 |
Gross Profit | 864.58 | 831.62 | 882.06 | 884.74 | 970.31 | 944.64 |
Selling, General & Admin | 688.98 | 699.7 | 716.98 | 656.64 | 616.32 | 637.45 |
Depreciation & Amortization Expenses | 15.04 | 14.95 | 21.29 | 12.38 | 13.88 | 16.91 |
Research & Development | 95 | 98.97 | 115.38 | 104.19 | 101.19 | 93.05 |
Other Operating Expenses | - | 511.37 | - | - | - | - |
Total Operating Expenses | 799.03 | 1,325 | 853.65 | 773.21 | 731.39 | 747.41 |
Operating Income | 65.56 | -493.37 | 28.41 | 111.53 | 238.92 | 197.23 |
Interest Income | 17.72 | 18.47 | 20.04 | 17.2 | 11.92 | 6.74 |
Interest Expense | -91.86 | -86.26 | -70.63 | -51.38 | -49.59 | -50.4 |
Other Non-Operating Income (Expense) | 8.41 | -2.35 | 3.94 | 3.72 | 12.65 | 61.11 |
Total Non-Operating Income (Expense) | -65.74 | -70.13 | -46.65 | -30.46 | -25.03 | 17.45 |
Pretax Income | -0.18 | -563.5 | -18.24 | 81.07 | 213.89 | 214.68 |
Provision for Income Taxes | 7.06 | -47.03 | -11.29 | 13.33 | 33.34 | 45.6 |
Net Income | -7.24 | -516.47 | -6.94 | 67.74 | 180.55 | 169.08 |
Net Income to Common | -7.24 | -516.47 | -6.94 | 67.74 | 180.55 | 169.08 |
Net Income Growth | - | - | - | -62.48% | 6.79% | 26.28% |
Shares Outstanding (Basic) | 77 | 77 | 77 | 80 | 83 | 85 |
Shares Outstanding (Diluted) | 77 | 77 | 77 | 80 | 84 | 85 |
Shares Change | 0.86% | -0.44% | -4.14% | -3.81% | -2.30% | 0.30% |
EPS (Basic) | -0.09 | -6.74 | -0.09 | 0.85 | 2.18 | 2.00 |
EPS (Diluted) | -0.09 | -6.74 | -0.09 | 0.84 | 2.16 | 1.98 |
EPS Growth | - | - | - | -61.11% | 9.09% | 26.11% |
Free Cash Flow | 25.8 | -31.05 | 24.96 | 73.09 | 222.13 | 264.41 |
Free Cash Flow Growth | - | - | -65.84% | -67.09% | -15.99% | 60.30% |
Free Cash Flow Per Share | 0.33 | -0.40 | 0.32 | 0.91 | 2.66 | 3.09 |
Gross Margin | 52.47% | 50.86% | 54.77% | 57.39% | 62.29% | 61.24% |
Operating Margin | 3.98% | -30.17% | 1.76% | 7.23% | 15.34% | 12.79% |
Profit Margin | -0.44% | -31.58% | -0.43% | 4.39% | 11.59% | 10.96% |
FCF Margin | 1.57% | -1.90% | 1.55% | 4.74% | 14.26% | 17.14% |
EBITDA | 219.07 | -341.54 | 169.3 | 235.04 | 357.22 | 317.07 |
EBITDA Margin | 13.30% | -20.89% | 10.51% | 15.25% | 22.93% | 20.56% |
EBIT | 65.56 | -493.37 | 28.41 | 111.53 | 238.92 | 197.23 |
EBIT Margin | 3.98% | -30.17% | 1.76% | 7.23% | 15.34% | 12.79% |
Effective Tax Rate | -3946.37% | 8.35% | 61.92% | 16.44% | 15.59% | 21.24% |